Delivery Order SPE2DR25D1002-SPE2DR26FGJ3M
Award Date 11/4/25
Potential Completion Date 11/5/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $26,868.47 by the Defense Logistics Agency (DLA) on July 14, 2025, for the supply of Ondansetron HCL 4 mg tablets in quantities of 30. The contract carries a firm fixed price structure with no set-aside designation, indicating competitive award status. Performance is based in Conshohocken, Pennsylvania, with an ultimate completion date of July 15, 2025. This delivery order represents a child contract issued under...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $3,589.87 for Ondansetron ODT 8 mg tablets (30-count) under a firm fixed price contract with the Defense Logistics Agency's Medical Supply Chain. The award was made on October 3, 2025, with an ultimate completion date of October 6, 2025, with performance to be executed in Conshohocken, Pennsylvania. This is an unset-aside, competitively awarded delivery order representing a continuation of AmerisourceBergen's extensive...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 1, 2025, by the Defense Logistics Agency's Medical Supply Chain to provide Ondansetron ODT 4 mg tablets (30-count) with a firm fixed price ceiling value of $5,173.92. The order is scheduled for completion by August 4, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This non-set-aside award represents a routine pharmaceutical procurement supporting federal medical supply needs, consistent with...
- AmerisourceBergen Drug Corp received a competitively awarded delivery order from the Defense Logistics Agency's Medical Supply Chain for Ondansetron ODT 4 mg tablets (30-count units) valued at $31,190.34. The contract was awarded on September 18, 2025, with an ultimate completion date of September 19, 2025, and carries firm fixed pricing with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this delivery order,...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) on September 29, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30, with a contract value of $14,262.22. This is a firm fixed-price, non-set-aside delivery order with a completion deadline of September 30, 2025. The awardee will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for Ondansetron ODT 4 mg tablets (30-count) valued at $4,536.73 under a firm fixed-price contract type. The award was made on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a non-set-aside award, indicating it was competitively awarded. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $47,359.92 for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This firm fixed-price contract was awarded on September 26, 2025, with an ultimate completion date of September 29, 2025, and is funded through the Defense Logistics Agency's Medical Supply Chain, which procures pharmaceuticals and medical supplies for...
- AmerisourceBergen Drug Corp was awarded a delivery order on October 29, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count packages) valued at $3,992.75. The contract is a firm fixed price delivery order with a completion date of October 30, 2025, and carries no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, and is funded through the Defense Medical Supply Chain, a component of the Department...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 12, 2025, for the supply of Ondansetron ODT 4 mg tablets in a 30-count package. This is a firm fixed-price, non-set-aside contract with a ceiling value of $5,923.61 and an ultimate completion date of September 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $6,100.80 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...